Literature DB >> 4546912

Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise.

J L Young, R B Boswell, A S Nies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4546912     DOI： 10.1001/archinte.134.3.553

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  23 in total

1.  Catatonia in the allopurinol hypersensitivity syndrome.

Authors:  C E Collins; D J Thomas; J M Gumpel
Journal:  BMJ       Date:  1991-04-20

2.  Predicting allopurinol response in patients with gout.

Authors:  Daniel F B Wright; Stephen B Duffull; Tony R Merriman; Nicola Dalbeth; Murray L Barclay; Lisa K Stamp
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

Review 3.  Diagnosis and management of gout: a rational approach.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

4.  Allopurinol-hypersensitivity vasculitis and liver damage.

Authors:  T D Boyer; N Sun; T B Reynolds
Journal:  West J Med       Date:  1977-02

5.  Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol.

Authors:  A Meyrier
Journal:  Br Med J       Date:  1976-08-21

6.  Hypersensitivity reactions to deoxycoformycin.

Authors:  P J O'Dwyer; S A King; E Eisenhauer; J L Grem; D F Hoth
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 8.  Clinical pharmacokinetics of allopurinol.

Authors:  G A Murrell; W G Rapeport
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

9.  Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout.

Authors:  Angelo L Gaffo; Kenneth G Saag
Journal:  Core Evid       Date:  2010-06-15

10.  Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.

Authors:  B Breithaupt; M Tittel
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.